Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuo Kanda

Showing results (1-10 of 459) with videos related to

Pageof 46
Sort By:
Hepatology International|April 26, 2021
No additive effects of peginterferon on the short-term improvement of liver histology by entecavir monotherapy in chronic hepatitis B patientsTatsuo Kanda
Journal of Gastrointestinal Oncology|May 22, 2026
When precision medicine meets human behavior: limits of artificial intelligence in predicting imatinib adherenceTatsuo Kanda
Translational Gastroenterology and Hepatology|August 28, 2018
Review gastrointestinal stromal tumors: to prospect the next decadeTatsuo Kanda
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|November 21, 2013
Criminal or bystander: imatinib and second primary malignancy in GIST patientsTatsuo Kanda
Translational Gastroenterology and Hepatology|February 1, 2017
Is a "wait-and-see" policy the best for small gastric gastrointestinal stromal tumor (GIST)?Tatsuo Kanda
International Journal of Molecular Sciences|April 13, 2023
Molecular Mechanism of Chronic Viral and Non-Viral Liver DiseasesTatsuo Kanda
Hepatology International|June 11, 2016
Interferon-free treatment for HCV-infected patients with decompensated cirrhosisTatsuo Kanda
Journal of Hepatocellular Carcinoma|August 11, 2016
The androgen receptor as an emerging target in hepatocellular carcinomaTatsuo Kanda, Osamu Yokosuka
Viruses|May 28, 2025
Thermal Inactivation of Hepatitis E Virus: A Narrative ReviewTatsuo Kanda, Hiroaki Okamoto
World Journal of Gastroenterology|September 9, 2017
Direct-acting antiviral agents against hepatitis C virus and lipid metabolismTatsuo Kanda, Mitsuhiko Moriyama
Pageof 46

Showing results (1-10 of 459) with videos related to

Sort By:
Pageof 46
Hepatology International|April 26, 2021
No additive effects of peginterferon on the short-term improvement of liver histology by entecavir monotherapy in chronic hepatitis B patientsTatsuo Kanda
Journal of Gastrointestinal Oncology|May 22, 2026
When precision medicine meets human behavior: limits of artificial intelligence in predicting imatinib adherenceTatsuo Kanda
Translational Gastroenterology and Hepatology|August 28, 2018
Review gastrointestinal stromal tumors: to prospect the next decadeTatsuo Kanda
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|November 21, 2013
Criminal or bystander: imatinib and second primary malignancy in GIST patientsTatsuo Kanda
Translational Gastroenterology and Hepatology|February 1, 2017
Is a "wait-and-see" policy the best for small gastric gastrointestinal stromal tumor (GIST)?Tatsuo Kanda
International Journal of Molecular Sciences|April 13, 2023
Molecular Mechanism of Chronic Viral and Non-Viral Liver DiseasesTatsuo Kanda
Hepatology International|June 11, 2016
Interferon-free treatment for HCV-infected patients with decompensated cirrhosisTatsuo Kanda
Journal of Hepatocellular Carcinoma|August 11, 2016
The androgen receptor as an emerging target in hepatocellular carcinomaTatsuo Kanda, Osamu Yokosuka
Viruses|May 28, 2025
Thermal Inactivation of Hepatitis E Virus: A Narrative ReviewTatsuo Kanda, Hiroaki Okamoto
World Journal of Gastroenterology|September 9, 2017
Direct-acting antiviral agents against hepatitis C virus and lipid metabolismTatsuo Kanda, Mitsuhiko Moriyama
Pageof 46